Updated:
120 Capital
120 Capital is a Life Science & Healthcare Venture Fund. It reports over $2B in AUM, more than 80 investments, and over 10 years of activity.
Overview
120 Capital is a Life Science & Healthcare Venture Fund. It reports over $2B in AUM, more than 80 investments, and over 10 years of activity. The firm highlights powerful science, visionary entrepreneurs, and extraordinary companies.
General information
Firm type
Private Equity
AUM
$2B +
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Principals
Leon Chen
Global Managing Director, CEO
Hannes Smárason
Senior Managing Director
Colin Wang
Managing Director
Sector focus
Frequently asked questions
What is known about 120 Capital's investment strategy?
Almost nothing. The firm describes itself as a private equity manager but has not disclosed target sectors, deal stage, check size, or geographic focus through public channels. No portfolio companies have been publicly linked to the firm, and no fund marketing documents or limited-partner disclosures are available for review.
How long has 120 Capital been operating?
The firm's founding year has not been publicly disclosed. Without a date of formation or initial deal activity on the public record, it is not possible to determine whether 120 Capital is a newly established vehicle or a long-standing entity that has operated below the radar.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: